Published on 2/26/2008 in the Prospect News Structured Products Daily.
New Issue: Barclays prices $1 million principal-protected notes linked to Merck
By Susanna Moon
Chicago, Feb. 26 - Barclays Bank plc priced $1 million of principal protected notes due Feb. 27, 2009 linked to the common stock of Merck & Co., Inc., according to a 424B2 filing with the Securities and Exchange Commission.
Investors will receive a conditional coupon of 14% if Merck stays within 14% of the initial level during the life of the notes. Investors will receive at least par.
Barclays Capital Inc. is the underwriter.
Issuer: | Barclays Bank plc
|
Issue: | 100% principal-protected notes
|
Underlying stock: | Merck & Co., Inc. (NYSE: MRK)
|
Amount: | $1 million
|
Maturity: | Feb. 27, 2009
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | 114% of par if Merck stock stays within 14% of initial price during life of notes; otherwise, par
|
Initial price: | $46.07
|
Lower barrier: | $39.6202, or 86% of initial price
|
Upper barrier: | $52.5198, or 114% of initial price
|
Pricing date: | Feb. 22
|
Settlement date: | Feb. 29
|
Underwriter: | Barclays Capital Inc.
|
Fees: | 1.5%
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.